Although these two enzymatic activities cannot be discriminated based on metabolomic analysis, the stronger mRNA expression of IDO1 compared to that of TDO in serous ovarian cancer tissues [18], and its considerably higher affinity and turnover rate for Trp [40], strongly point towards IDO1 as the major contributor. Here, TDO2 is linked to ovarian serous adenocarcinoma.